Form 8-K - Current report:
SEC Accession No. 0001520138-24-000376
Filing Date
2024-10-22
Accepted
2024-10-22 16:01:02
Documents
14
Period of Report
2024-10-22
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20241022_8k.htm   iXBRL 8-K 30968
2 EXHIBIT 99.1 bivi-20241022_8k99z1.htm EX-99.1 11073
  Complete submission text file 0001520138-24-000376.txt   222326

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bivi-20241022.xsd EX-101.SCH 3027
4 XBRL LABEL FILE bivi-20241022_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bivi-20241022_pre.xml EX-101.PRE 24173
16 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20241022_8k_htm.xml XML 3568
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 241386324
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)